Last reviewed · How we verify
NCT06059417
Foam Tape Allergy a Sticky Situation
NA trial testing 2x2 inch piece of 3M microfoam adhesive in Medical Adhesive Allergy in 40 participants. Completed in 13 September 2022.
13 September 2022
Quick facts
| Lead sponsor | CHRISTUS Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 1 August 2021 |
| Primary completion | 13 September 2022 |
| Estimated completion | 13 September 2022 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- 2x2 inch piece of 3M microfoam adhesive
Conditions studied
- Medical Adhesive Allergy — all drugs for Medical Adhesive Allergy →
- Dermatologic Conditions — all drugs for Dermatologic Conditions →
- Dermatologic Lesions — all drugs for Dermatologic Lesions →
Sponsor
CHRISTUS Health — full company profile →
Who can join
Adults 18 to 70, any sex, with Medical Adhesive Allergy or Dermatologic Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Foam tape is commonly used in the emergency department as a dressing over chest tubes owing to its occlusive and compressible properties. There is a paucity of data regarding the incidence of significant cutaneous reactions to this material. The investigators conducted a prospective trial to evaluate the incidence of dermatitis following application of foam tape to the upper arm of a cohort of healthy volunteers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The incidence of dermatitis following application of foam tape in healthy volunteers-A prospective trial.
Vo NH, Richman P, Torres R, Xu KT, et al · · 2024 · PMID 38462426 · DOI 10.1016/j.ajem.2024.02.043
Verify or expand the search:
- PubMed search for NCT06059417
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other CHRISTUS Health trials
Trials by the same sponsor.
- NCT06726811 — Droperidol and QTc Interval Changes in ED Patients · recruiting
- NCT06555315 — Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic) · NA · recruiting
- NCT06589284 — Skin Glue Versus Suture for Securing Radial Arterial Lines · NA · completed
- NCT04869579 — Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients. · Phase 2 · unknown
- NCT06437301 — End Tidal CO2 and Masks: Is There a Correlation? · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06059417 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CHRISTUS Health
- Last refreshed: 26 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06059417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing